Back

An expert rheumatologist reviews current treatment options in rheumatoid arthritis, focusing on tumor necrosis factor-α inhibitors (TNFi) and the molecular signature response classifier (MSRC) test.

Expert Perspectives on Advances in Precision Medicine in Treating Rheumatoid Arthritis

Episodes

Specialty:

All

Year:

All

Please check back later for more content.

Expert Perspectives on Advances in Precision Medicine in Treating Rheumatoid Arthritis

Episodes

Trending on HCPLive

Atacicept and Upstream Immune Targeting in IgAN With Richard Lafayette, MD

Culprits in Perioperative Allergy, With Kimberly Blumenthal, MD

Enlicitide’s FDA Approval for LDL-C Reduction and the CORALreef Outcomes Trial

Prior Authorization, Precision Medicine, and Eczema Remission, With Jason Hawkes, MD

Moving the Needle in Medicine: Innovation, Leadership, and the Future of Heart Failure, With Philip Adamson, MD, MSc